|
1
|
Geschwind JF: Locoregional therapy for
patients with hepatocellular carcinoma. Gastroenterol Hepatol (NY).
11:698–700. 2015.
|
|
2
|
Gish RG: Hepatocellular carcinoma: Current
questions and future directions. Gastroenterol Hepatol (NY).
11:182–185. 2015.
|
|
3
|
Geschwind JF: Locoregional therapy for
patients with hepatocellular carcinoma. Clin Adv Hematol Oncol.
13:660–662. 2015.PubMed/NCBI
|
|
4
|
Janevska D, Chaloska-Ivanova V and
Janevski V: Hepatocellular carcinoma: Risk factors, diagnosis and
treatment. Open Access Maced J Med Sci. 3:732–736. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tawfik O, Garimella R, Tancabelic J,
Keighley J, Pinson D, Khan Q and Templeton K: Retrospective
immunohistochemical study of VDR, RXR, Ki-67, and Bcl-2 expression
in primary and metastatic osteosarcoma. J Clin Oncol.
27:e215162009.
|
|
6
|
Li W, Zhang G, Wang HL and Wang L:
Analysis of expression of cyclin E, p27kip1 and Ki67 protein in
colorectal cancer tissues and its value for diagnosis, treatment
and prognosis of disease. Eur Rev Med Pharmacol Sci. 20:4874–4879.
2016.PubMed/NCBI
|
|
7
|
Saponara M, Di BM, Lolli C, Derenzini E,
Pantaleo MA, Santini D, Ceccarelli C, Catena F, Nannini M and
Maleddu A: Evaluation of Ki-67 in gastrointestinal stromal tumor
(GIST). J Clin Oncol. 27:e215102009.
|
|
8
|
Sirlin C: Imaging techniques for
hepatocellular carcinoma. Gastroenterol Hepatol (NY). 11:403–405.
2015.
|
|
9
|
Dong Y, Wang WP, Mao F, Fan M, Ignee A,
Serra C, Sparchez Z, Sporea I, Braden B and Dietrich CF: Contrast
enhanced ultrasound features of hepatic cystadenoma and hepatic
cystadenocarcinoma. Scand J Gastroenterol. 52:365–372. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Haimerl M, Poelsterl S, Beyer LP,
Wiesinger I, Niessen C, Stroszczynski C, Wiggermann P and Jung EM:
Chronic liver disease: Quantitative MRI vs CEUS-based
microperfusion. Clin Hemorheol Microcirc. 64:435–446. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lekovic D, Gotic M, Skoda R,
Beleslin-Cokic B, Milic N, Mitrovic-Ajtic O, Nienhold R, Sefer D,
Suboticki T, Buac M, et al: Bone marrow microvessel density and
plasma angiogenic factors in myeloproliferative neoplasms:
Clinicopathological and molecular correlations. Ann Hematol.
96:393–404. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang S, Zhang D, Yi S, Gong M, Lu C, Cai
Y, Tang X and Zou L: The relationship of lymphatic vessel density,
lymphovascular invasion, and lymph node metastasis in breast
cancer: A systematic review and meta-analysis. Oncotarget.
8:2863–2873. 2017.PubMed/NCBI
|
|
13
|
Poon RT, Ng IO, Lau C, Yu WC, Yang ZF, Fan
ST and Wong J: Tumor microvessel density as a predictor of
recurrence after resection of hepatocellular carcinoma: A
prospective study. J Clin Oncol. 20:1775–1785. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Donat M, Alonso S, Pereira F, Ferrero E,
Carrión L, Acin-Gándara D and Moreno E: Impact of histological
factors of hepatocellular carcinoma on the outcome of liver
transplantation. Transplant Proc. 48:1968–1977. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Feng LH, Dong H, Lau WY, Yu H, Zhu YY,
Zhao Y, Lin YX, Chen J, Wu MC and Cong WM: Novel microvascular
invasion-based prognostic nomograms to predict survival outcomes in
patients after R0 resection for hepatocellular carcinoma. J Cancer
Res Clin Oncol. 143:293–303. 2017. View Article : Google Scholar : PubMed/NCBI
|
